BRIAN CLANCY: Open Payments
NPI 1083151898 · FAIRFIELD, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,376 in 180 payments from 21 companies in 2025. Trend: 2023 $3,485 · 2024 $3,524 · 2025 $5,376
Food & beverage: $3,867Consulting: $1,245Education: $192Travel & lodging: $71
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 18 | $2,130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 25 | $641 |
| ABBVIE INC. | 24 | $543 |
| Madrigal Pharmaceuticals | 28 | $440 |
| Lilly USA, LLC | 17 | $297 |
| Ipsen Biopharmaceuticals, Inc | 14 | $274 |
| PFIZER INC. | 15 | $201 |
| QOL Medical, LLC | 7 | $190 |
| Phathom Pharmaceuticals, Inc. | 5 | $109 |
| Ardelyx, Inc. | 5 | $100 |
Products named: TREMFYA, ENTYVIO, REZDIFFRA, OMVOH, IQIRVO, Sucraid, SKYRIZI, VELSIPITY.
Industry payments across CT — which companies pay providers there.
